基于多状态模型的瘤临床试验设计规划,该模型共同模拟无进展和整体生存终点
Alexandra Erdmann1, Jan Beyersmann1, Kaspar Rufibach2
1Institute of Statistics, Ulm University, Ulm, Germany.
Biometrical journal. Biometrische Zeitschrift
|December 17, 2024
概括
标准瘤学临床试验规划经常使用整体生存期 (OS) 和无进展生存期 (PFS) 的简化假设. 这项研究展示了一个生存多状态模型,用于联合分析OS和PFS,揭示这些假设往往失败,并可能导致不足的试验.
科学领域:
- 生物统计学 生物统计学
- 临床试验设计 临床试验设计
- 瘤学研究研究
背景情况:
- 传统的瘤学临床试验规划通常假设相对危险和指数分布对于时间到事件的终点,如总生存率 (OS) 和无进展生存率 (PFS).
- 这些简化假设可能不能准确地反映临床试验中多个依赖终点之间的复杂关系.
研究的目的:
- 在瘤学临床试验中引入和应用生存多状态模型,共同分析OS和PFS.
- 通过考虑终点依赖性和不成比例的危险,展示该模型如何改善临床试验的规划和设计.
主要方法:
- 利用生存多态模型,一种随机过程方法,共同建模OS和PFS之间的依赖关系.
- 采用基于多状态模型的模拟研究来解决临床试验设计问题,包括共同初级终点和组序列设计.
- 开发了一个可在CRAN上使用的R包,用于实施拟议的方法.
主要成果:
- 发现当联合建模时,OS和PFS的指数分布和比例危险通常不会同时存在.
- 证明至少一个终点的不成比例危险是OS和PFS之间的依赖的自然结果.
- 模拟结果表明,标准简化方法可能导致临床试验不足或过度.
结论:
- 生存多状态模型提供了一个更强大的框架,用于在瘤学试验中共同建模OS和PFS等依赖终点.
- 这种方法允许更准确的临床试验设计和规划,通过自然结合终点依赖性和不成比例的危险.
- 该方法可用于更复杂的试验设计,额外的终点和其他治疗领域.
相关概念视频
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Kaplan-Meier Approach
94
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
94
Comparing the Survival Analysis of Two or More Groups
149
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
149
Assumptions of Survival Analysis
96
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
96
Actuarial Approach
61
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
61
Introduction To Survival Analysis
180
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
180


